BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15080932)

  • 1. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
    Park JD; Kim DH
    Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.
    Wang SH; Wang SF; Xuan W; Zeng ZH; Jin JY; Ma J; Tian GR
    Bioorg Med Chem; 2008 Apr; 16(7):3596-601. PubMed ID: 18289863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
    Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
    J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase A.
    Cross JB; Vreven T; Meroueh SO; Mobashery S; Schlegel HB
    J Phys Chem B; 2005 Mar; 109(10):4761-9. PubMed ID: 16851559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of alpha-nitromethyl ketone as a new zinc-binding group based on structural analysis of its complex with carboxypeptidase A.
    Wang SF; Tian GR; Zhang WZ; Jin JY
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5009-11. PubMed ID: 19646864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a mechanism for reactive inhibition of carboxypeptidase A with QM/MM methods.
    Phoon L; Burton NA
    J Mol Graph Model; 2005 Oct; 24(2):94-101. PubMed ID: 16144767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gem-dialkyl succinic acids: a novel class of inhibitors for carboxypeptidases.
    Asante-Appiah E; Seetharaman J; Sicheri F; Yang DS; Chan WW
    Biochemistry; 1997 Jul; 36(29):8710-5. PubMed ID: 9220957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry-based design of inhibitors for carboxypeptidase A.
    Kim DH
    Curr Top Med Chem; 2004; 4(12):1217-26. PubMed ID: 15320722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography.
    Kim H; Lipscomb WN
    Biochemistry; 1991 Aug; 30(33):8171-80. PubMed ID: 1868092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway.
    Lee KJ; Kim DH
    Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible inhibition of zinc-containing protease by oxazolidinone derivatives. Novel inactivation chemistry.
    Kim DH; Chung SJ; Kim EJ; Tian GR
    Bioorg Med Chem Lett; 1998 Apr; 8(7):859-64. PubMed ID: 9871555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the stereochemistry in the inhibition of carboxypeptidase A with N-(hydroxyaminocarbonyl)phenylalanine: binding modes of an enantiomeric pair of the inhibitor to carboxypeptidase A.
    Cho JH; Kim DH; Chung SJ; Ha NC; Oh BH; Yong Choi K
    Bioorg Med Chem; 2002 Jun; 10(6):2015-22. PubMed ID: 11937361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in vitro activities of new non-peptidic APA inhibitors.
    Inguimbert N; Coric P; Dhotel H; Bonnard E; Llorens-Cortes C; Mota N; Fournié-Zaluski MC; Roques BP
    J Pept Res; 2005 Feb; 65(2):175-88. PubMed ID: 15705162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic sulfamide HIV-1 protease inhibitors, with sidechains spanning from P2/P2' to P1/P1'.
    Ax A; Schaal W; Vrang L; Samuelsson B; Hallberg A; Karlén A
    Bioorg Med Chem; 2005 Feb; 13(3):755-64. PubMed ID: 15653343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantum mechanics-based scoring function: study of zinc ion-mediated ligand binding.
    Raha K; Merz KM
    J Am Chem Soc; 2004 Feb; 126(4):1020-1. PubMed ID: 14746460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
    Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
    Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of sulfamides as enzyme inhibitors.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Med Res Rev; 2006 Nov; 26(6):767-92. PubMed ID: 16710859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Benzyl-2-methylsuccinic acid as inhibitor for carboxypeptidase A. synthesis and evaluation.
    Lee M; Jin Y; Kim DH
    Bioorg Med Chem; 1999 Aug; 7(8):1755-60. PubMed ID: 10482467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
    Chung SJ; Kim DH
    Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
    Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
    Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.